Stock:
Symbol Lookup
Register | Login
...
History
...
...

Pre Market | Dow Jones | Gold | Newsletters | Learn


Sequenom - SQNM - 2012 was a year of remarkable progress for Sequenom

Monday, January 7, 2013 11:17 AM
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, announced preliminary highlights of the Company's 2012 performance and accomplishments. SQNM - Initial 2012 Performance Results (unaudited)
  • Total revenue of approximately $89 million, growth of approximately 59 percent year-over-year for 2012
  • Diagnostic services revenues of approximately $46 million, compared to $8.3 million in 2011.  Diagnostic services revenues continue to be recorded primarily as cash is received
  • Sales in the Genetic Analysis business of approximately $43 million
  • More than 92,000 total prenatal and retinal diagnostic tests accessioned during the year
  • Strong increases in the adoption rate and sales of Sequenom Center for Molecular Medicine's (Sequenom CMM) MaterniT21 PLUS lab-developed test (LDT):
    • More than 60,000 MaterniT21 PLUS tests accessioned in 2012
    • An annualized run rate of more than 120,000 MaterniT21 PLUS tests accessioned at the end of 2012
    • Approximately 56 million lives under coverage with growing number of payor contracts
    • Continued reimbursement as an out-of-network laboratory from large commercial payors
  • Total cash, cash equivalents, and marketable securities as of December 31, 2012 were approximately $176 million
  • Cash burn of approximately $17 million for the fourth quarter of 2012
"2012 was a year of remarkable progress for Sequenom.  The rapid adoption of the Sequenom CMM's MaterniT21 PLUS by the OB/GYN physician community far exceeded the Company's internal goal and the estimates of industry analysts.  The joint recommendation by the American College of Obstetricians and Gynecologists (ACOG) and the Society of Maternal and Fetal Medicine (SMFM) for the use of noninvasive prenatal tests (NIPT) such as the MaterniT21 PLUS in high risk pregnancies provided an additional validation for this technology.  The company also exceeded the majority of its other goals as it established Sequenom CMM as a leader in the prenatal testing market," said Harry F. Hixson, Jr, Ph.D., Chairman and CEO of Sequenom.  "We look forward to the continued growth of the MaterniT21 PLUS LDT in 2013 and the corresponding increase in test capacity.  We plan to work with national and regional payors to establish additional contracts facilitating the availability of the MaterniT21 PLUS LDT to high-risk pregnant women throughout the United States." About Sequenom - SQNM Sequenom, Inc. (SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. SQNM was founded in 1994 and is headquartered in San Diego, California.
PRINT

FREE Options Trading Lessons
I'll show you how to unlock HUGE Gains with Options Trading
Let's make 2014 the year you get RICH!

Latest Headlines

Credit Suisse loans under U.S. Fed scrutiny: WSJCredit Suisse loans under U.S. Fed scrutiny: WSJ
(Reuters) - The U.S. Federal Reserve has asked Credit Suisse Group AG <CSGN.VX> to immediately address problems relating to the bank`s underwriting and sale of leveraged loans, or high-interest-...
Even funds sour on Russia stay sweet on MagnitEven funds sour on Russia stay sweet on Magnit
BOSTON/MOSCOW (Reuters) - Would you believe one of the West`s favorite Russian stocks is a provincial grocery chain? Western fund managers have stockpiled shares in Russia`s largest food retailer,...
Fed could hint on rate-hike plans as it prepares for policy turnFed could hint on rate-hike plans as it prepares for policy turn
WASHINGTON (Reuters) - The U.S. Federal Reserve on Wednesday could offer fresh clues on when it plans to begin lifting interest rates and how quickly it will move, as it prepares for a momentous pol...
Dollar on edge as Fed language eyed, Aussie surgesDollar on edge as Fed language eyed, Aussie surges
SYDNEY (Reuters) - The U.S. dollar nursed modest losses early on Wednesday, having suffered an unexpected setback as jitters mounted hours before the Federal Reserve offers its latest guidance on in...
Microsoft boosts dividend 11 percent, adds new directorsMicrosoft boosts dividend 11 percent, adds new directors
SEATTLE (Reuters) - Microsoft Corp <MSFT.O> on Tuesday announced an 11 percent increase in its quarterly dividend and appointed two new directors to replace two board members who decided not to ...

Loading Headlines...
 

Stock Market

Track the stock market today with the latest news and information on all things investing! Watch your stocks perform throughout the day and watch the breaking stock market news.

Feedback | disclaimer | privacy policy

Stock Market News

The Stock Market is ever changing. Keep up on your stock market news.

Stock Market Newsletters

Read up on your favorite stock market newsletters.


Learn the Stock Market

Sharper your stock trading skills with our stock market education section.